Mutual Advisors, LLC Biond Vax Pharmaceuticals Ltd. Transaction History

Mutual Advisors, LLC

  • $3.5 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$2.5 - $40.97 $17,877 - $292,976
-7,151 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$23.7 - $51.1 $169,478 - $365,416
7,151 New
7,151 $280,000

About BiondVax Pharmaceuticals Ltd.

BVXV Quotes by TradingView
  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Mutual Advisors, LLC Portfolio

Follow Mutual Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email